about
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesisCombined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic micePersonalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA AnalysisGenetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapiesNuclear phospholipase C beta1 (PLCbeta1) affects CD24 expression in murine erythroleukemia cells4th Pediatric Allergy and Asthma Meeting (PAAM)SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological preventionThe progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST)Pooled genome-wide analysis to identify novel risk loci for pediatric allergic asthmaIntegrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).IKKα/CHUK regulates extracellular matrix remodeling independent of its kinase activity to facilitate articular chondrocyte differentiation.Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation.The expression of ccn3(nov) gene in musculoskeletal tumorsSDHC methylation in gastrointestinal stromal tumors (GIST): a case report.PDL1 expression is an independent prognostic factor in localized GIST.The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kitWhole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome.Genomic Grade Index predicts postoperative clinical outcome of GIST.Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS)Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney.Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice.Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression.An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).Insulin-like Growth Factor (IGF) system and gastrointestinal stromal tumours (GIST): present and future.Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array.miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia.Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.
P50
Q24642797-544E5F97-25E5-4987-902F-28598D98DCB7Q24670549-8E0078E6-F43D-458D-B327-8CDD04907E68Q26800005-D058FEC2-27D7-4494-A59F-D5BEC355E136Q26852049-83BE3DFF-E618-4F68-BB54-B4E986C895F1Q28593187-7935F4CB-98B9-431B-81F3-7C9A4B5F0FA2Q28818630-CD1F6E9B-769E-4854-A31C-B34981D6E8A5Q30401988-7B5BDC5E-D884-4528-8150-E4369A4762E6Q33229377-DA458303-49BE-4994-A641-B2EC20E193A9Q33722723-F306FD6A-67DD-470F-B038-D1F8A582E7CCQ33832076-30C1FCE3-2366-4CC1-942D-D3BF3F7BCCE2Q34274467-3F833BD7-16AF-4B38-8186-DD3761C24267Q34984184-3A21587F-5046-4740-988A-0FFC62E42AF6Q35083847-C1087672-B7F5-470B-BD5D-8E72ACFCAB56Q35564082-D8A0E3D4-9E10-4C26-AE8C-98E40FCBBB12Q35788810-BCC902C0-02BD-4AAB-896E-AE45367527F9Q35790835-58F9ED0A-052D-4E37-B621-7DA182F88B18Q35798839-E1B19988-0E6F-46CB-869D-73A10C833058Q35829711-09B7B355-5401-4493-AD00-AB1FC86C3B8BQ35831238-F7007E64-4B83-4E55-A34F-180E38071A26Q36086354-D764B7A5-EB28-4B54-AF66-7554A9668ADDQ36387916-403122E0-1183-4BC0-8FEB-E764243C5EE6Q36561734-D04991AA-D804-4F9E-B976-08447B15DE75Q36562222-60C7179D-5F33-4987-B533-C3B7282BB460Q36977583-8CA46FD6-28C8-46E8-A912-B05071D9DB24Q37331742-EC8803AA-14DA-48CB-9FC0-34ACD01D324BQ37350278-92E0E8F3-C7B0-4025-A573-CBDC0BF8FF43Q37397647-8A122594-ECA8-47E2-B864-5B06D2667A8DQ37597243-576B06FA-24EA-44D3-8718-DBFF7B2CC7D5Q37649646-0ED5D92C-B0EE-42E6-AF95-1649203A3D00Q37688851-3897B3A3-5CD9-4193-B75F-99D3E0E43A8CQ38119931-80374963-328D-4F82-95B2-74C117D58144Q38152981-34B4C358-AD32-4AE8-AA10-82C8B8DBA258Q38295459-6A88BDF6-A71F-40CE-93FF-F5FF492925DBQ38296380-39F00BFF-2112-4049-9581-F8FA17F5A36EQ38602174-3AAD07C4-231D-4989-A8A3-50BE57982FBBQ38724862-71259C8D-C8B2-49CF-BBEB-51DF14B585E9Q39221970-3BA03E7B-3593-41A6-BC4D-1F44366167F3Q39314094-2569ABB2-D951-4CDB-9D9B-09E183673139Q39409643-CDAE55B0-3F97-42C9-BB96-4D7EB9017F8BQ39446630-103D7C08-AAF7-49E7-93F1-ABF23FEE5BB5
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Annalisa Astolfi
@ast
Annalisa Astolfi
@en
Annalisa Astolfi
@es
Annalisa Astolfi
@nl
type
label
Annalisa Astolfi
@ast
Annalisa Astolfi
@en
Annalisa Astolfi
@es
Annalisa Astolfi
@nl
prefLabel
Annalisa Astolfi
@ast
Annalisa Astolfi
@en
Annalisa Astolfi
@es
Annalisa Astolfi
@nl
P106
P1153
7005785178
P21
P31
P496
0000-0002-2732-0747